<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-06T11:58:57Z</responseDate>
  <request identifier="oai:figshare.com:article/34073781" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34073781</identifier>
        <datestamp>2026-10-05T17:53:00Z</datestamp>
        <setSpec>category_915</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Pharmacodynamic parameters of drug action as calculated from the corresponding heat flow curves with &lt;i&gt;T. b. rhodesiense&lt;/i&gt; STIB900 (Fig 6). Drug concentrations are given in multiples of the respective IC50 for ease of reference to published data [9, 26].&lt;/p&gt;</dc:title>
          <dc:creator>Monica Cal (1637389)</dc:creator>
          <dc:creator>Sonja Keller (25317282)</dc:creator>
          <dc:creator>Romina Rocchetti (448977)</dc:creator>
          <dc:creator>Stéphanie Braillard (23758820)</dc:creator>
          <dc:creator>Jean-Robert Ioset (115415)</dc:creator>
          <dc:creator>Pascal Mäser (87895)</dc:creator>
          <dc:creator>Marcel Kaiser (41510)</dc:creator>
          <dc:subject>Physical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>tsetse fly vectors</dc:subject>
          <dc:subject>resistant field isolate</dc:subject>
          <dc:subject>fatal unless treated</dc:subject>
          <dc:subject>exhibits irreversible cidality</dc:subject>
          <dc:subject>dose oral cure</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>human african trypanosomiasis</dc:subject>
          <dc:subject>trypanosoma brucei &lt;/</dc:subject>
          <dc:subject>acoziborole also needs</dc:subject>
          <dc:subject>brucei &lt;/</dc:subject>
          <dc:subject>human body</dc:subject>
          <dc:subject>african trypanosomes</dc:subject>
          <dc:subject>rhodesiense &lt;/</dc:subject>
          <dc:subject>r &lt;/</dc:subject>
          <dc:subject>gambiense &lt;/</dc:subject>
          <dc:subject>g &lt;/</dc:subject>
          <dc:subject>≥ 4</dc:subject>
          <dc:subject>trypanocidal action</dc:subject>
          <dc:subject>tropical africa</dc:subject>
          <dc:subject>therefore conclude</dc:subject>
          <dc:subject>sleeping sickness</dc:subject>
          <dc:subject>rural areas</dc:subject>
          <dc:subject>preclinical dossier</dc:subject>
          <dc:subject>infectious diseases</dc:subject>
          <dc:subject>historic low</dc:subject>
          <dc:subject>high activity</dc:subject>
          <dc:subject>former accounting</dc:subject>
          <dc:subject>focal prevalence</dc:subject>
          <dc:subject>faster acting</dc:subject>
          <dc:subject>elusive disease</dc:subject>
          <dc:subject>efficacy profiling</dc:subject>
          <dc:subject>depth evaluation</dc:subject>
          <dc:subject>clinical development</dc:subject>
          <dc:subject>bloodstream forms</dc:subject>
          <dc:subject>6 μg</dc:subject>
          <dc:subject>3 μm</dc:subject>
          <dc:subject>15 h</dc:subject>
          <dc:description>&lt;p&gt;Pharmacodynamic parameters of drug action as calculated from the corresponding heat flow curves with &lt;i&gt;T. b. rhodesiense&lt;/i&gt; STIB900 (&lt;a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0014762#pntd.0014762.g006" target="_blank"&gt;Fig 6&lt;/a&gt;). Drug concentrations are given in multiples of the respective IC50 for ease of reference to published data [&lt;a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0014762#pntd.0014762.ref009" target="_blank"&gt;9&lt;/a&gt;, &lt;a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0014762#pntd.0014762.ref026" target="_blank"&gt;26&lt;/a&gt;].&lt;/p&gt;</dc:description>
          <dc:date>2026-10-05T17:52:49Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pntd.0014762.t004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Pharmacodynamic_parameters_of_drug_action_as_calculated_from_the_corresponding_heat_flow_curves_with_i_T_b_rhodesiense_i_STIB900_Fig_6_Drug_concentrations_are_given_in_multiples_of_the_respective_IC50_for_ease_of_reference_to_published_d/34073781</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
